Carbohydrate antigens aberrantly expressed in colorectal carcinoma

Critical Reviews in Oncology/Hematology

Volumn 25, Issue 1, 1997, Pages 27-54

  Matsushita, Yoshifumi ^a   Yonezawa, Suguru ^a   Nakamori, Shoji ^b   Irimura, Tatsuro ^c   Sato, Eiichi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CENTER FOR ADULT DISEASES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; BLOOD GROUP LEWIS SYSTEM; COLORECTAL CARCINOMA; HUMAN; REVIEW;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARBOHYDRATE SEQUENCE; COLORECTAL NEOPLASMS; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 0030970180     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(96)00227-2     Document Type: Review

References (303)

1. [1] Kirsner JB, Shorter RG, eds. Diseases of the Colon, Rectum, and Anal Canal. Baltimore: Williams and Wilkins. 1988: 371-394.
2. [2] Levin B. Neoplasmas of the large and small intestines. In: Wyngaarden JB, Smith Jr LH, Bennett JC, eds. Cecil Textbook of Medicine, 19th edn. Philadelphia: W.B. Saunders, 1992: 713-720.
3. [3] Silverberg E, Lubera J. Cancer statistics, 1987. Ca Cancer J Clin 37:2-19, 1987.
4. [4] Kurihara M, Aoki K, Tominaga S. eds. Cancer Mortality Statistics in the World. 1950-1985. The University of Nagoya Press, 1989.
5. [5] Kashtan H, Werbin N, Aladjem D, Barak Y, Wiznitzer T. Right and left colon carcinoma: as retrospective comparative study. J Surg Oncol 35:245-248, 1987.
6. [6] Tanaka S, Nakamura T, Sato E. Survival and pathological difference between carcinoma of the sigmoid colon and of the ileocecum. Jpn J Cancer Clin 27:1349-1354. 1981 (in Japanese with English abst.).
7. [7] Eisenberg B, Decosse JJ, Harford F, Michalek J. Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients. Cancer 49:1131-1134, 1982.
8. [8] Eastwood M. Food, drugs, bile and enterobacterial interactions. In: Kirsnar JB, Shorter RG, eds. Disease of the Colon, Rectum, and Anal Canal. Baltimore: Williams and Wilkins, 1988: 133-156.
9. [9] Dukes CE. The classification of cancer of the rectum. J Pathol 35:323-332, 1932.
10. [10] Astler VA, Coller FA. The prognostic significance of direct extension of the colon and Rectum. Ann Surg 139:846-852, 1984.
11. [11] Newland RC, Dent OF, Chapuis PH, Bokey EL. Clinicopathologically diagnosed residual tumor after resection for colorectal cancer. A 20-year prospective study. Cancer 72:1536-1542, 1993.
12. [12] Miller W, Ota D, Giacco G, Duinee J, Irimura T, Nicolson GL, Cleary KR. Absence of relationship of size of primary colon carcinoma with metastasis and survival. Clin Exp Metastasis 3:189-196, 1985.
13. [13] Wolmark N, Curz I, Redmond CK, Fisher B, Fisher ER. Contributing NSABP Investigation. Tumor size and regional lymph node metastasis in colorectal cancer: primary analysis from the NSABP clinical trials. Cancer 51:1315-1322, 1983.
14. [14] De Mascarel A, Coinder JM, de Mascarel I, Trojani M, Marfee MaD, Hoerni B. The prognostic significance of specific histologic features of carcinoma of he colon and rectum. Surg Gynecol Obst 153:511-514, 1981.
15. [15] Dawson PM, Habib NA, Rees HC, Williamson RCN, Wood CB. Influence of sialomucin at the resection margin on local tumor recurrence and survival of patients with colorectal cancer: a multivariate analysis. Br J Surg 74:366-369, 1987.
16. [16] Halvorsen TB, Seim E. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis. J Clin Pathol 41:1068-1072, 1988.
17. [17] Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H. Clowes memorial award lecture. Cancer Res 50:6130-6138, 1990.
18. [18] Guadagni F, Roselli M, Cosimelli M, Mannella E, Tedesco M, Cavaliere F, Grassi A, Abbolito MR, Greiner JW, Schlom J. TAG-72 (CA72-4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer 72:2098-2106, 1993.
19. [19] Shimano T, Okuda H, Monden T, Inaji T, Mori T. Usefulness of carcinoembryonic antigen measurement in feces of patients with colorectal cancer. Dis Colon Rectum 30:607-610, 1987.
20. [20] Turunen MJ, Liewendahl K, Partanen P, Adlercreutz H. Immunological detection of faecal occult blood in colorectal cancer. Br J Cancer 49:141-148, 1984.
21. [21] Dubrow R, Yannielli L. Fecal protein markers of colorectal cancer. Am J Gastroenterol 87:854-858, 1992.
22. [22] Nakayama T, Yasuoka H, Kishino T, Kishino T, Ohguchi H, Takada M. ELISA for occult faecal albumin. Lancet 1, 1368-1369, 1987.
23. [23] Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256:102-104, 1992.
24. [24] Helwig EB. The evolution of adenomas of the large intestine and their relation to carcinoma. Surg Gynecol Obstet 84:36-49, 1947.
25. [25] Morson BC. Precancerous lesions of the colon and rectum. JAMA 179:316-321, 1962.
26. [26] Enterline HT, Evans GW, Mercado-Lugo R, Miller L, Fitts WT. Malignant potential of adenomas of colon and rectum. JAMA 179:110-118, 1962.
27. [27] Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer 36:2251-2270, 1975.
28. [28] Konishi F, Morson BC. Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol 35:830-841, 1982.
29. [29] Grandquist S. Distribution of polyps in the large bowel in relation to age. A colonoscopic study. Scand J Gastroenterol 16:1025-1031, 1981.
30. [30] Morson BC. Evolution of cancer of the colon and rectum. Cancer 34:845-849, 1974.
31. [31] Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy 25:455-461, 1993.
32. [32] Lynch HT. Frequency of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and II). Gastroenterology 90:486-496, 1986.
33. [33] Lynch HT, Bronson EK, Strayhorn PC, Smyrk TC, Lynch JF, Ploetner EJ. Genetic diagnosis of Lynch syndrome II in an extended colorectal cancer-prone family. Cancer 66:2233-2238, 1990.
34. [34] Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb A, Vogelstein B. Prevalence of ras gene mutation in human colorectal cancers. Nature 327:293-297, 1987.
35. [35] Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327:298-303, 1987.
36. [36] Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR, Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scambler P, Sheer D, Solomon E, Spurr NK. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328:614-616, 1987.
37. [37] Solomon E, Voss R, Hall V, Bodmer WF, Jass JR, Jeffreys AJ, Lucibello FC, Patel I, Rider SH. Chromosome 5 allele loss in human colorectal carcinoma. Nature 328:616-619, 1987.
38. [38] Leppert M, Dobbs M, Scambler P, O'Connell P, Nakamura Y, Stauffer D, Woodward S, Burt R, Hughes J, Gardner E, Lathrop M, Wasmuth J, Lalouel J-M, White R. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238:1411-1413, 1987.
39. [39] Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 238:193-197, 1987.
40. [40] Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61:759-767, 1990.
41. [41] Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smith AMM, Bos JL. Genetic alterations during colorectal-tumor development. New Engl J Med 319:525-532, 1988.
42. [42] Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 54:271-335, 1993.
43. [43] Kim H, Yang X-L, Rosada C, Hamilton S, August T. CD44 expression in colorectal adenoma is an early event occurring prior to K-ras and p53 mutation. Arch Biochem Biophys 310:504-507, 1994.
44. [44] Wielenga VJ, Heider K-H, Offerhaus GJA, Adolf GR, van den Berg FM, Ponta H, Herrlich P, Pals ST. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754-4756, 1993.
45. [45] Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME. Evidence for novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80:200-204, 1988.
46. [46] Leone A, Flatow U, King CR, Sandeen MA, Margulies IMK, Liotta LA, Steeg PA. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65:25-35, 1991.
47. [47] Florenes VA, Amadal S, Myklebost O, Maelandsmo M, Bruland OS, Fodstad O. Levels of nm23 messenger RNA in metastatic malignant melanomas:Inverse correlation to disease progression. Cancer Res 52:6088-6091, 1992.
48. [48] Barnes R, masood S, Barker E, Rosengard AM, Coggin DL, Crowell T, King CR, Porter-Jordan K, Wargotz ES, Liotta LA, Steeg PS. Low nm23 protein expression in infiltrating ductal breast carcinoma correlates with reduced patient survival. Am J Pathol 139:245-250, 1991.
49. [49] Haut M, Steeg PS, Willson JKV, Markowitz SD. Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst 83:712-716, 1991.
50. [50] Ayhan A, Yasui W, Yokozaki H, Kitadai Y, Tahara E. Reduced expression of nm23 protein is associated with tumor stage and distant metastases in human colorectal carcinomas. Virchows Arch B 63:213-218, 1993.
51. [51] Iino H, Fukuyama M, Maeda Y, Koike M, Mori T, Takahashi T, Kikuchi-Yanoshita R, Miyaki M, Mizuno S, Watanabe S. Molecular genetics for clinical management of colorectal carcinoma. 17p, 18q, and 22q loss of heterozygosity and decreased expression are correlated with metastatic potential. Cancer 73:1324-1331, 1994.
52. [52] Ookawa K, Sakamoto M, Hirohashi S, Yoshida Y, Sugimura T, Terada M, Yokota J. Concordant p53 and DCC alterations and allelic losses on chromosome 13q and 14q associated with liver metastases of colorectal carcinoma. Int J Cancer 53:382-387, 1993.
53. [53] De Baetselier P, Katzav S, Gorelik E, Feldman M, Segal S. Differential expression of H-2 gene products in tumor cells is associated with their metastatogenic properties. Nature 288:179-181, 1980.
54. b gene. Proc Natl Acad Sci USA 85:4463-4467, 1988.
55. [55] Pradler-Pohl A, Pohl J, Schirrmacher V. Selective enhancement of metastatic capacity in mouse bladder carcinoma cells after transfection with DNA from liver matastases of human colon carcinoma. Int J Cancer 41:840-846, 1988.
56. [56] Markowitz SD, Myeroff L, Cooper MJ, Traicoff J, Kochera M, Lutterbaugh J, Swiriduk M, Willson JKV. A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene. J Clin Invest 93:1005-1013, 1994.
57. [57] Nicolson GL. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res 47:1473-1487, 1987.
58. [58] Feizi T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 314:53-57, 1985.
59. [59] Fillipe MI. Value of histochemical reactions for mucosubstances in the diagnosis of certain pathological conditions of the colon and rectum. Gut 10:577-586, 1969.
60. [60] Gold DV, Miller F. Comparison of human colonic mucoprotein antigen from normal and neoplastic mucosa. Cancer Res 38:3204-3211, 1978.
61. [61] Podolsky DK. Oligosaccharide structures of human colonic mucin. J Biol Chem 260: 8262-8271, 1985.
62. [62] Finne J, Breimer ME, Hansson GC, Karlson K-A, Leffler H, Vliegenhart JFG, Halbeek Hv. Novel polyfucosylated N-linked glycopeptides with blood group A, H, X, and Y determinants from human small intestinal epithelial cells. J Biol Chem 264:5720-5735, 1989.
63. [63] Gold P, Freedman SO. Demonstration of tumor-specific antigen in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 121:439-462, 1965.
64. [64] Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen, HF. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Eng J Med 199:448-451, 1978.
65. [65] Goslin R, Steele Jr. G, MacIntyre J, Mayer R, Sugarbaker P, Cleghorn K, Wilson R, Zamcheck N. The use of preoperative plasma CEA level for the stratification of patients after curative resection of colorectal cancers. Ann Surg 192:747-751, 1980.
66. [66] Oikawa S, Nakazato H, Kosaki G. Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence. Biochem Biophys Res Comm 142:511-518, 1987.
67. [67] Beauchemin N, Benchumol S, Cournoyer D, Fuks A, Stanner CP. Isolation and characterization of full-length functional cDNA clones for human carcinoembryonic antigen. Mol Cell Biol 7:3221-3230, 1987.
68. [68] Barnett T, Goebel SJ, Nothdurft MA, Elting JJ. Carcinoembryonic antigen family: characterization of cDNAs coding for NCA and CEA and suggestion of nonrandom sequence variation in their conserved loop domains. Genomics 3:59-66, 1988.
69. [69] Hefta LJF, Chen F-S, Ronks M, Sautter SJ, Sarin V, Oikawa S, Nakazato H, Hefta S, Shivery JE. Expression of carcinoembryonic antigen and its predicted immunoglobulin-like domains in Hela cells for epitope analysis. Cancer Res 52:5647-5655, 1992.
70. [70] Yamashita K, Totani Y, Kuroki M, Matsuoka Y, Ueda A, Kobata K. Structural studies of the carbohydrate moieties of carcinoembryonic antigen. Cancer Res 47:3451-3459, 1987.
71. [71] Yamashita K, Totani Y, Iwaki M, Kuroki Y, Matsuoka T, Endo A, Kobata A. Carbohydrate structures of NCA-2, a glycoprotein purified from meconium as an antigen cross-reacting with anti-CEA antibody:Occurrence of complex type sugar chain with Galβ1-3GlcNAcβ1-3Galβ1-4GlcNAcβ1-outer chain. J Biol Chem 264:17873-17881, 1989.
72. [72] Oikawa S, Imajo S, Noguchi T, Kosaki G, Nakazato H. The carcinoembryonic antigen (CEA) contains multiple immunoglobulin-like domains. Biochem Biophys Res Comm 144:634-642, 1987.
73. [73] Williams AF, Barclay AN. The immunoglobulin superfamily-domains for cell surface recognition. Ann Rev Immunol 6:381-405, 1988.
74. [74] Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57:327-334, 1989.
75. [75] Pignatelli M, Durbin H, Bodmer WF. Carcinoembryonic antigen functions as an accessory adhesion molecule mediating colon epithelial cell-collagen interaction. Proc Natl Acad Sci USA 87:1541-1545, 1990.
76. [76] Zhou H, Stanners CP, Fuks A. Specificity of anti-carcinoembryonic antigen monoclonal antibodies and their effects on CEA-mediated adhesion. Cancer Res 53:3817-3822, 1993.
77. [77] Kanai T, Hibi T, Hayashi A, Takahashi J, Shiozawa M, Aiso S, Toda K, Iwao Y, Watanabe M, Tsuchiya M. Carcinoembryonic antigen mediates in vitro cell aggregation induced by interferon-γ in a human colon cancer cell line: requirement for active metabolism and intact cytoskelton. Cancer Lett 71:109-117, 1993.
78. [78] Hostetter RB, Augustus LB, Mankarious R, Chi K, Fan D, Toth C, Jessup ML. Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis. J Natl Cancer Inst 82:380-385, 1990.
79. [79] Ishii S, Steele Jr. G, Ford R, Paliotti G, Thomas P, Andrews C, Hansen HJ, Goldenberg DM, Jessup JM. Normal colonic epithelium adheres to carcinoembryonic antigen and type-IV collagen. Gastroenterology 106:1242-1250, 1994.
80. [80] Durrant LG, Denton GWL, Jacobs E, Mee M, Moss R, Austin EB, Baldwin RW, Hardcastle JD, Robins RA. An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours. Int J Cancer 50:811-816, 1992.
81. [81] Watkins WM. Blood group substances. Science 152:172-181, 1966.
82. [82] Humphries MJ, Matsumoto K, White SL, Olden K. Inhibition of experimental metastasis by castanospermine in mice: Blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res 46:5215-5222, 1986.
83. [83] Sharon N, Lis H. Lectins: Cell-agglutinating and sugar-specific proteins. Science 177:949-959, 1972.
84. [84] Goldstein IJ, Hughes RC, Monsigny M, Osawa T, Sharon N. What should be called a lectin? Nature 285:66, 1980.
85. [85] Osawa T, Tsuji T. Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins. Ann Rev Biochem 56:21-42, 1987.
86. [86] Yonezawa S, Nakamura T, Tanaka S, Sato E. Glycoconjugate xvith Ulex europaeus-1-binding sites of normal mucosa, adenoma, and carcinoma of the human large bowel. J Natl Cancer Inst 71:19-24, 1982.
87. [87] Matsushita Y, Yonezawa S, Nakamura T, Shimizu S, Ozawa M, Muramatsu T, Sato E. Carcinoma-specific Ulex europaeus agglutinin-I binding glycoproteins of human colorectal carcinoma and its relation to carcinoembryonic antigen. J Natl Cancer Inst 75:219-226, 1985.
88. [88] Irimura T, Ota DM, Cleary KR. Ulex europaeus agglutinin I-reactive high molecular weight glycoproteins of adenocarcinoma of distal colon and rectum and their relationship with metastatic potential. Cancer Res 47:881-889, 1987.
89. [89] Matsumoto I, Osawa T. On the specificity of various heterologous anti-H hemagglutinins. Vox Sang 21:548-557, 1971.
90. [90] Boland CR, Montgomery CK, Kim YS. Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Pro Natl Acad Sci USA 79:2051-2055, 1982.
91. [91] Boland CR, Montgomery CK, Kim YS. A cancer-associated mucin alteration in benign colonic polyps. Gastroenterology 82:664-672, 1982.
92. [92] Boland CR, Roberts J. Quantitation of lectin binding sites in human colon mucin by use of peanut and wheat germ agglutinins. J Histochem Cytochem 36:1305-1307, 1988.
93. [93] Cooper HS, Reuter VE. Peanut lectin-binding sites in polyp of the colon and rectum. Lab Invest 49:655-661, 1983.
94. [94] Springer GF. T and Tn. General carcinoma autoantigens. Science 224:1198-1206, 1984.
95. [95] Boland CR, Lance P, Levin B, Riddell RH, Kim YS. Abnormal goblet cell glycoconjugates in rectal biopsies associated with an increased risk of neoplasia in patients with ulcerative colitis: early results of a prospective study. Gut 25:1364-1371, 1984.
96. [96] Fozard JBJ, Dixon MF, Axon ATR, Giles GR. Lectin and mucin histochemistry as aid to cancer surveillance in ulcerative colitis. Histopathology 11:385-394, 1987.
97. [97] Nakayama J, Okano A, Maeda H, Miyachi M, Ota H, Katsuyama T, Kanai M. Griffonia simplicifolia agglutinin-2-binding glycoprotein as a novel carbohydrate antigen of human colonic carcinoma. Jpn J Cancer Res 81:388-395, 1990.
98. [98] Irimura T, Carlson DA, Price J, Yamori T, Giavazzi R, Ota DM, Cleary KR. Differential expression of a sialoglycoprotein with an approximate molecular weight of 900 000 on metastatic human colon carcinoma cells growing in culture and in tumor tissue. Cancer Res 48:2353-2360, 1988.
99. [99] Dennis J. Different metastatic phenotypes in two genetic classes of wheat germ agglutinin-resistant tumor cell mutants. Cancer Res 46:4594-4600, 1986.
100. [100] Dennis J, Laferte S, Waghorne C, Breitmen ML, Kerbel RS. β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236:582-585, 1987.
101. [101] Dennis J, Laferte S. Oncodevelopmental expression of -Glc-NAcβ1-6Manχ 1-6Manβ1-branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas. Cancer Res 49:945-950, 1989.
102. [102] Bresalier RS, Rockwell RW, Dahiya R, Duh Q-Y, Kim YS. Cell surface sialoprotein alterations in metastatic colon cancer cell lines selected in an animal model for colon cancer metastasis. Cancer Res 50:1299-1307, 1990.
103. [103] Kawai T, Suzuki M. Histochemical and biochemical aspects of lectin binding glycoproteins in primary and metastatic adenocarcinoma in the lung. Modern Pathol 7:175-180, 1994.
104. [104] Finne J, Tao T-W, Burger MM. Carbohydrate changes in glycoproteins of a poorly metastasizing wheat germ agglutinin-resistant melanoma clone. Cancer Res 40:2580-2587, 1980.
105. [105] Boland CR, Chen Y-F, Rinderle SJ, Resau JH, Luk GD, Lynch HT, Goldstein IJ. The use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells. Cancer Res 51:657-665, 1991.
106. [106] Sata T, Roth J, Zuber C, Stamm B, Rinderle SJ, Goldstein IJ, Heitz PU. Studies on the Thomsen-Friedenreich antigen in human colon with the lectin Amaranthin. Normal and neoplastic epithelium express only cryptic antigen. Lab Invest 66, 175-186, 1992.
107. [107] Kamada Y, Muramatsu H, Muramatsu T. Glycopeptides from murine teratocarcinoma cells: Structure of the determinants recognized by griffonia simplicifolia agglutinin and by sera from patients with ovarian germ cell tumor. Carbohydrate Res 176:237-243, 1988.
108. [108] Raz A, Pazerini G, Carmi P. Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-bindmg protein. Cancer Res 49:3489-3493, 1989.
109. [109] Irimura T, Matsushita Y, Sutton RC, Carrakero D, Ohannesian DW, Cleary KR, Ota DM, Nicolson GL, Lotan R. Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stage. Cancer Res 51:387-393, 1991.
110. [110] Lotan R, Matsushita Y, Ohannesian D, Carralero D, Ota DM, Cleary DM, Nicolson GL, Irimura T. Lactose-binding lectin expression in human colorectal carcinomas. Relation to tumor progression. Carbohydrate Res 213:47-57, 1991.
111. [111] Koehler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497, 1975.
112. [112] Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52:257-331.
113. [113] Yang JM, Byrd JC, Siddiki BB, Chung YS, Okuno M, Sowa M, Kim YS, Matta KL, Brockhausen I. Alterations of O-glycan biosynthesis in human colon cancer tissue. Glycobiology 4:873-884, 1994.
114. [114] Samuel J, Noujain AA, MacLean GD, Suresh MR, Longenecker BM. Analysis of human tumor associated Thomsen Friedenreich antigen. Cancer Res 50:4801-4808, 1990.
115. [115] Hounsell E, Lawson AM, Feeney J, Gool HC, Pickering NJ, Stoll MS, Lui SC, Feizi T. Structural analysis of the o-glycosidically linked core-region oligasaccharides of human meconium glycoproteins which express oncofetal antigens. Eur J Biochem 166:367-377, 1985.
116. [116] Colcher D, Horan HP, Nuti M, Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 78:3199-3208, 1981.
117. [117] Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J. Distribution of oncofetal antigen TAG-72 defined by monoclonal antibody B72.3. Cancer Res 46:3118-3124, 1986.
118. [118] Sheer DG, Schlom J, Cooper HL. Purification and comparison of the human tumor associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3. Cancer Res 48:6811-6818, 1988.
119. [119] Kjeldsen T, Clausen H, Hirohashi S, Ogawa T, Iijima H, Hakomori S-I. Preparation and characterization of monoclonal antibody directed to the tumor-associated o-linked sialosyl-2-6 χ-N'-Acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res 48:2214-2220, 1988.
120. [120] Kurosaka A, Kitagawa H, Fukui S, Nomura Y, Nakada H, Funakoshi I, Kawasaki T, Ogawa T, Iijima H, Yamashina I. A monoclonal antibody that recognizes a cluster of a disaccharide NeuAc χ 2-6 GalNAc, in mucin-type glycoproteins. J Biol Chem 263:8724-8725, 1988.
121. [121] Appeddu PA, Shur BD. Molecular analysis of cell surface β-1,4-galactosyltransferase function during cell migration. Proc Natl Acad Sci USA 91:2095-2099, 1994.
122. [122] Schuessler MH, Pintado S, Welt S, Real FX, Melamed MR, Llyod KO, Oettgen HF. Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: Enhanced expression of precursor type 1. Tn and sialyl-Tn in pancreas cancer. Int J Cancer 47:180-187, 1991.
123. [123] Itzkowitz SH, Bloom EJ, Kim YS. Mucin associated Tn and sialosyl-Tn antigen expression in colorectal polyps. Gut 33: 518-523, 1992.
124. [124] Yonezawa S, Tachikavva T, Shin S, Sato E. Sialosyl-Tn antigen. Its distribution in normal tissues and expression in adenocarcinomas. Am J Clin Pathol 98:167-174, 1992.
125. [125] Tashiro Y, Yonezawa S, Kim YS, Sato E. Immunohistochemical study of mucin carbohydrate core proteins in human ovarian tumors. Human Pathol 25:364-372, 1994.
126. [126] Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S-I, Kim YS, Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 66:1960-1966, 1990.
127. [127] Inoue M, Ogawa H, Nakanishi K, Tanizawa O, Karino K, Endo J. Clinical value of sialyl Tn antigen in patients with gynecologic tumors. Obstet Gynecol 75:1032-1036, 1990.
128. [128] Dall'Olio F, Malagolini N, Di Stefano G, Ciambella M, Serafini-Cessi F. χ.2,6 sialylation of N-actyllactosaminic sequences in human colorectal cancer cell lines. Relationship with non-adherent growth. Int J Cancer 47:291-297, 1991.
129. [129] Bresalier RS, Hujanen ES, Raper SE, Roll FJ, Itzkowitz SH, Martin GR, Kim murine cell lines with enhanced liver-metastasizing ability. Cancer Res 47:1398-1406, 1987.
130. [130] Ogata S, Maimonis PJ, Itzkowitz SH. Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxity. Cancer Res 52:4741-4746, 1992.
131. [131] O'Boyle K, Zamore R, Adluri S, Cohen A, Kemeny N, Welt S, Lloyd KO, Oettgen HF, Old KJ, Livingston PO. Immunization of colorectal cancer patient with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn. Cancer Res 52:5663-5667, 1992.
132. [132] Piera M, de Bolos C, Castro R, Real FX. Cytokines as adjuvants: effect on the immunogenicity of NeuAcχ2-6GalNAcχ-O-Ser/Thr (Sialyl-Tn). Int J Cancer 55:148-152, 1993.
133. [133] Voshol H, Dullens HFJ, Otter WD, Vliegenthart FG. Cell surface glycoconjugates as possible target structures for human natural killer cells: Evidence against the involvement of glycolipids and N-linked carbohydrate chains. Glycobiology 3:69-76, 1993.
134. [134] Qi Y, Moyana T, Matte G, Wilkinson A, Bresalier R, Xiang J. Immunolocalization of hepatic metastases of human colonic cancer by chimeric anti-TAG72 antibody in SCID mice. J Surg Oncol 59:3-8, 1995.
135. [135] Blottiere HM, Burg C, Zennadi R, Perrin P, Blanchardie P, Bara J, Meflah K, Le Pendu J. Involvement of histo-blood-group antigens in the susceptibility of colon carcinoma cells to natural killer-mediated cytotoxity. Int J Cancer 52:609-618, 1992.
136. [136] Watkins WM. Biochemistry and genetics of the ABO, Lewis, P blood group systems. Adv Hum Genet 10:1-136, 1980.
137. [137] Kabat EA. Philip Levine Award Lecture. Contribution of Quantitative immunochemistry to knowledge of blood group A, B. H, Le, I and i antigens. Am J Clin Pathol 78:281-292, 1982.
138. [138] Llyod KO. Philip Levine Award Lecture. Blood group antigens as markers for normal differentiation and malignant changes in human tissue. Am J Clin Pathol 87:129-139, 1987.
139. [139] Ernst LK, Rajan VP, Larsen RD, Ruff MM, Lowe JB. Stable expression of blood group H determinants and GDP-L-fucose: β-D-Galactoside 2-χ-L-fucosyltransferase in mouse cells after transfection with human DNA J Biol Chem 264:3436-3447, 1989.
140. [140] Clausen H, White T, Takio K, Titani K, Stroud M, Holmes E, Karkov J, Thim L, Hakomori S. Isolation to homogeneity and partial characterization of a histo-blood group A defined Fucχ1-2Galχ1-3-N-acetylgalactosaminyltransferase from human lung tissue. J Biol Chem 265:1139-1145, 1990.
141. [141] Yamamoto F, Marken J, Tsuji T, White T, Clausen H, Hakomori S. Cloning and characterization of DNA complementary to human UDP-GalNAc:Fucχ1-2Galχ1-3GalNAc transferase (Histo-blood group A transferase) mRNA. J Biol Chem 265:1146-1151, 1990.
142. [142] Yamamoto F, Clausen H, White T, Marken J, Hakomori S. Molecular genetic basis of the histo-blood group ABO system. Nature 345:229-233, 1990.
143. [143] Yamamoto F, Hakomori S. Sugar-nucleotide donor specificity of histo-blood group A and B transferases is based on amino acid substitutions. J Biol Chem 265:19257-19262, 1990.
144. [144] Larsen RD, Ernst LK, Nair Rp, Lowe JB. Molecular cloning, sequence, expression of a human GDP-L-fucose: β-D-Galactoside 2-χ-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci USA 87:6674-6678, 1990.
145. [145] Kukowska-Latallo JF, Larsen RD, Lowe JB. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and Lewis blood group χ(1,3/1,4) fucosyltransferase. Genes Dev 4:1288-1303, 1990.
146. [146] Hakomori S. Philip Levine Award Lecture: Blood group glycolipid antigens and their modifications as human cancer antigens. Am J Clin Pathol 82:635-649, 1984.
147. b) and type 2 (X, Y, H) blood group-related antigens in human pyloric and duodenal mucosae. Lab Invest 53:219-227, 1985.
148. [148] Yuan M, Itzkowitz SH, Palekar A, Shamusddin AM, Phelps PC, Trump BF, Kim YS. Distribution of blood group antigens A, B, H, Lewisa, and Lewisb in human normal, fetal, and malignantcolonic tissue. Cancer Res 4:4499-4511, 1985.
149. [149] Sakamoto J, Furukawa K, Cordon-Cardo C, Yin BW, Rettig WJ, Oettgen HF, Old LJ, Lloyd KO. Expression of Lewis a, Lewis b, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res 46:1553-1556, 1986.
150. [150] Coon JS, Weinstein RS. Blood group-related antigens as markers of malignant potential and heterogeneity in human carcinoma. Hum Pathol 17:1089-1106, 1986.
151. [151] Miyake M, Taki T, Hitomi S, Hakomori S. Correlation of expression of H/LeY/Le b antigens with survival in patients with carcinoma of the lung. New Eng J Med 327:14-18, 1992.
152. [152] Cordon-Cardo C, Lloyd KO, Sakamoto J, McGroarty ME, Old LJ, Melamed MR. Immunohistologic expression of blood-group antigens in normal human gastrointestinal tract and colonic carcinoma. Int J Cancer 37:667-676, 1986.
153. [153] Koprowski H, Herlyn M, Steplewski Z, Sears HF. Specific antigen in serum of patients with colon carcinoma. Science 212:53-55, 1981.
154. [154] Magnani JL, Brockhaus M, Smith DF, Ginsburg V, Blaszczyk M, Mitchell KF, Steplewski A, Koprowski H. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 212:55-56, 1981.
155. [155] Magnani JL, Nilsson B, Brockhaus M, Zopf D, Steplewski Z, Koprowski H, Ginsburg V. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem 257:14365-14369, 1982.
156. [156] Magnani JL, Steplewski Z, Koprowski H, Ginsburg V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res 43:5489-5492, 1983.
157. [157] Fukuda M, Spooncer E, Oates JE, Dell A, Klock JC. Structure of sialylated fucosyl lactosainoglycan isolated from human granulocytes. J Biol Chem 259:10925-10935, 1984.
158. [158] Kitagawa H, Nakada H, Fukui S, Kawasaki T, Yamashina I. Characterization of mucin-type oligosaccharides with the sialyl-Le a structure from human colorectal adenocarcinoma cells. Biochem Biophys Res Comm 178:1429-1436, 1991.
159. a structure from human rectal adenocarcinoma. J Biol Chem 268:26541-26545, 1993.
160. [160] Pettijohn DE, Pfenninger O, Brown J, Duke R, Olsson L. Tumorigeneic human squamous lung cancer cells have defined cell surface carbohydrates that absent from nontumorigenic cells. Proc Natl Acad Sci USA 85:802-806, 1988.
161. 6) as human tumor-associated antigen. J Biol Chem 266:8439-8446, 1991.
162. a structure in human milk. J Biochem 114:504-508, 1993.
163. [163] Metzgar RS, Rodriguez N, Finn O, Lan MS, Daasch VN, Fernsten PD, Meyers WC, Sindelar WF, Sandler RS, Seigler HF. Detection of pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci USA 81:5242-5246, 1984.
164. 4) of human colonic adenocarcinoma and the monoclonal antibody (FH7) defining this structure. J Biol Chem 261:5487-5495, 1987.
165. [165] Itai S, Nishikata J, Yoneda T, Ohmori K, Yamabe H, Arii S, Tobe T, Kannagi R. Tissue distribution of 2-3 and 2-6 sialyl Lewis A antigens and significance of the ratio of two antigens for the differential diagnosis of malignant and benign disorders of the digestive tract. Cancer 67:1576-1687, 1991.
166. [166] Liepkalns VA, Icard-Liepkalns C. Retinoic-acid-induced augmentation of molecular species carrying sialosyl Lewis a antigen in colorectal carcinoma cell cultures. Int J Cancer 55:256-261, 1993.
167. [167] Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1) Proc Natl Acad Sci USA 75:5565-5569, 1978.
168. [168] Gooi HC, Feizi T, Kapadia A, Knowles BB, Solter D, Evans MJ. Stage-specific embryonic antigen involves χ1-3 fucosylated type 2 blood group chains. Nature 292:156, 1982.
169. [169] Kannagi R, Nudelman E, Levery SB, Hakomori S. A series of human erythrocyte sphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen, SSEA-1. J Biol Chem 257:14865-14874, 1982.
170. [170] Kannagi R, Nudelman E, Hakomori S. Possible role of ceramide in defining structure and function of membrane glycolipids. Proc Natl Acad Sci USA 79:3470-3474, 1982.
171. [171] Fenderson BA, Zehavi U, Hakomori S. A multivalent lacto-N-fucopentose III-lysyllysine conjugate decompacts preimplantation mouse embryos, while the free oligosaccharide is ineffective J Exp Med 160:1591-1596, 1984.
172. X determinants. A possible basis for cell recognition in preimplantation embryos and in embryonal carcinoma cells. J Biol Chem 264:9476-9484, 1989.
173. [173] Miyake M, Zenita K, Tanaka O, Okada Y, Kannagi R. Stage-specific expression of SSEA-1-related antigens in the developing lung of human embryos and its relation to the distribution of these antigens in lung cancers. Cancer Res 48:7150-7158, 1988.
174. [174] Itai S, Nishikata J, Takahashi N, Tanaka O, Matsubara Y, Hasegawa S, Yanai N, Takaoka K, Arii S, Tobe T, Kannagi R. Differentiation-dependent expression of I and sialyl I antigens in developing lung of human embryos and in lung cancers. Cancer Res 50:7603-7611, 1990.
175. [175] Abe K, Hakomori S, Oshiba S. Differential expression of difucosyl type 2 chain (LeY) defined by monoclonal antibody AH6 in different locations of colonic epithelia, various histological types of colonic polyps, and adenocarcinoma. Cancer Res 46:2639-2644, 1986.
176. [176] Yonezawa S, Nakamura T, Tanaka S, Maruta K, Nishi M, Sato E. Binding of Ulex europaeus agglutinin-I polyposis coli: Comparative study with solitary adenoma in the sigmoid colon and rectum. J Natl Cancer Inst 71:19-24, 1983.
177. Y blood group-related antigens in human malignant, premalignant, and nonmalignant colonic tissues. Cancer Res 46:5982-5992, 1986.
178. X-related antigen expression in human malignant colonic tissue. Cancer Res 46, 2627-2632, 1986.
179. [179] Yuan M, Itzkowitz SH, Ferrell LD, Fukushi Y, Palekar A, Hakomori S, Kim YS. Expression of LewisX and sialylated LewisX antigens in human colorectal polyps. J Natl Cancer Inst 78:479-488, 1987.
180. [180] Sato E, Yonezawa S, Nakamura T, Matsushita Y, Inoue H, Kitajima S, Tsuji Y. Immunohistological analysis of colorectal adenomas by a new monoclonal antibody C12 and Ulex lectin. In: Ohyama M, Muramatsu T, eds. Proc. Kagoshima Int Symp Glycoconj in Medicine, 1986: 233-237.
181. [181] Tsuji Y, Yoshioka M, Ogasawara T, Takemura T, Isojima S. Identification of an H-antigen-like blood group antigen in sera of patients using a new novel monoclonal antibody raised against endometrial carcinoma. Cancer Res. 47:3543-3550, 1987.
182. [182] Garrigues J, Anderson J, Hellstroem KE, Hellstroem I. Anti-tumor antibody BR96 blocks cell migration and binds to a lysozomal membrane glycoprotein on cell surface microspikes and ruffled membrane. J Cell Biol 125:129-142, 1994.
183. [183] Ogawa J, Sano A, Inoue H, Koide S. Expression of Lewis-related antigen and prognosis in stage-1 non-small cell lung carcinoma. Ann Thorac Surg 59:412-415, 1995.
184. [184] Hiraishi K, Suzuki K, Hakomori S, Adachi M. LeY antigen expression is correlated with apoptosis (programmed cell death). Glycobiology 3:381-390, 1993.
185. [185] Singhal AK, Orntoft TF, Nudelman E, Nance S, Schibig L, Stroud MR, Clausen H, Hakomori S. Profiles of Lewis X-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma. Cancer Res 50:1375-1380, 1990.
186. [186] Hakomori S, Nudelman E, Levery SB, Kannagi R. Novel fucolipid accumulating in human adenocarcinoma I. Glycolipids with di-or trifucosylated type-2 chain. J Biol Chem 259:4672-4680, 1984.
187. [187] Fukushi Y, Hakomori S, Nudelman E, Cochran N. Novel fucolipids accumulating in human adenocarcinoma II. Selective isolation of hybridoma antibodies that differentially recognized mono-, di-, and trifucosylated type 2 chain. J Biol Chem 259:4681-4685, 1984.
188. 6). J Biol Chem 259:10511-10517, 1984.
189. [189] Fukushima K, Hirota M, Terasaki PI, Wakisaka A, Togashi H, Chia D, Suyama N, Fukushi Y, Nudelman E, Hakomori S. Characterization of sialosylated LewisX as a new tumor-associated antigen. Cancer Res 44:5279-5285, 1984.
190. 6) in normal and tumor tissues defined by its monoclonal antibody FH6. Cancer Res 45:3711-3717, 1985.
191. [191] Le Pendu J, Caillard T, Mollicone R, Couillin P, Oriol R. Expression of ABH and X (Le X) antigens in various cells. Biochemie 70:1613-1617, 1988.
192. [192] Ohmori K, Yoneda T, Shigela K, Hirashima K, Kanai M, Itai S, Sasaoki T, Arii S, Arita H, Kannagi R. Sialyl SSEA-1 antigen as a carbohydrate marker of human natural killer cells and immature lymphoid cells. Blood 74:255-261, 1989.
193. [193] Hozawa K, Wataya H, Takasaki T, Fenderson BA, Hakomori S. Hearing and glycoconjugates: localization of LeY, LeX, sialosyl-LeX in guinea pig cochlea, particularly at the tectorial membrane and sensory epithelia of the organ of Corti. Glycobiology 3:47-55, 1993.
194. [194] Ohmori K, Takada A, Yoneda T, Buma Y, Hirashima K, Tsuyuoka K, Hasegawa A, Kannagi R. Differentiation-dependent expression of sialyl-specific embryonic antigen-1 and I-antigens on human lymphoid cells and its implications for carbohydrate-mediated adhesion to vascular endothelium. Blood 81:101-111, 1993.
195. [195] Ross EL, Barker JNWN, Allen MH, Chu AC, Groves RW, MacDonald DM. Langerhans' cell expression of the selectin ligand, sialyl Lewis X. Immunology 81:303-308, 1994.
196. [196] Hoff SD, Matsushita Y, Ota DM, Cleay KR, Yamori T, Hakomori S, Irimura T. Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Cancer Res 49:6883-6888, 1989.
197. [197] Hoff SD, Irimura T, Matsushita Y, Ota DM, Cleary KR, Hakomori S. Metastatic potential of colon carcinoma. Expression of ABO Lewis-related antigens. Arch Surg 125:206-209, 1990.
198. [198] Matsushita Y, Cleary KR, Ota DM, Hoff SD, Irimura T. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases. Lab Invest 63:780-791, 1990.
199. [199] Irimura T, Matsushita Y, Hoff SD, Yamori T, Nakamori S, Frazer MI, Giacco GG, Cleary KR, Ota DM. Ectopic expression of mucins in colorectal cancer metastasis. Sem Cancer Biol 2:129-139, 1991.
200. [200] Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Iwaniga T, Matsushita Y, Irimura T. Increased expression of sialyl LewisX antigen correlates with colorectal carcinoma:Clinicopathological and immunohistochemical study. Cancer Res 53:3632-3637, 1993.
201. X lipids. J Biochem 103:998-1003, 1988.
202. [202] Nakagoe T, Fukushima K, Hirota M, Kusano H, Ayabe H, Tomita M, Kamihira S. Immunohistochemical expression of sialyl LeX antigen in relation to survival of patients with colorectal carcinoma. Cancer 72:2323-2330, 1993.
203. [203] Hanski C, Bornhoeft G, Topf N, Herman U, Stein H, Riecken FO. Detection of a mucin marker for the adenoma-carcinoma sequence in human colonic mucosa by monoclonal antibody AM-3. J Clin Pathol 43:379-385, 1990.
204. [204] Hanisch F-G, Hanski C, Hasegawa A. Sialyl LewisX antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in colonic adenoma-carcinoma sequence. Cancer Res 52:3138-3144, 1992.
205. [205] Hanski C, Stolze B, Riecken EO. Tumorigenicity, mucin production and AM-3 epitope expression in clones selected from the HT-29 colon carcinoma cell line. Int J Cancer 50:924-929, 1992.
206. X antigen. Clin Exp Metastasis 9:283-299, 1991.
207. X antigen. Exp Cell Res 196:20-25, 1991.
208. [208] Irimura T, Nakamori S, Matsushita Y, Taniuchi Y, Todoroki N, Tsuji T, Izumi Y, Kawamura Y, Hoff SD, Cleary KR, Ota DM. Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion:role of sialyl-Lex antigens. Sem Cancer Biol 4:319-324, 1993.
209. X carbohydrate antigen: Liver colonization and adhesion to vascular endothelial cells. Exp Cell Res 216:215-221, 1995.
210. [210] Dahiya R, Lesuffleur T, Kwak K-S, Byrd JC, Barbat A, Zweibaum A, Kim YS. Expression and characterization of mucins associated with the resistance to methotrexate of human colonic adenocarcinoma cell line HT29. Cancer Res 52:4655-4662, 1992.
211. [211] Fukushima K, Tskasaki S. Suppressive role of sialylated N-glycans in Fc receptor-mediated phagocytosis by macrophages. Biochem Biophys Res Comm 192:333-337.
212. [212] Yamori T, Ota DM, Cleary KR, Hoff S, Hager LG, Irimura T. Monoclonal antibody against human colonic sulfomucin: immunochemical detection of its binding sites in colonic mucosa. colorectal carcinomas and liver metastasis. Cancer Res 49:887-894, 1989.
213. [213] Irimura T, Wynn DM, Hager LG, Cleary KR, Ota DM. Human colonic sulfomucin identified by a specific antibody Cancer Res 51:5728-5735, 1991.
214. [214] Matsushita Y, Yamamoto N, Shirahama H, Tanaka S, Yonezawa S, Yamori T, Irimura T, Sato E. Expression of sulfotnueins in normal mucosae, colorectal adenocarcinoma, and metastases. Jpn J Cancer Res 86:1060-1067, 1995.
215. [215] Ohe Y, Hinoda Y, Irimura T, Imai K, Yachi A. Expression of sulfated carbohydrate chains detected by monoclonal antibody 91.9H in human gastric cancer tissues. Jpn J Cancer Res 85:400-408, 1994.
216. [216] Lampe Bv, Stallmach A, Riecken EO. Altered glycosylation of integrin adhesion molecules in colorectal cancer cells and decreased adhesion to the extracelular matrix. Gut 34:829-836, 1993.
217. [217] Helling F, Shang A, Calves M, Zhang S, Ren S, Yu RK, Oettgen HF, Livingston PO. GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines. Cancer Res 54:197-203, 1994.
218. [218] Holmes EH, Ostrander GK, Hakomori S. Enzymatic basis for the accumulation of glycolipids with X and dimeric X determinants in human lung cancer cells (NCI-H69). J Biol Chem 260:7619-7626, 1985.
219. 2nLc) in human lung carcinoma PC9 cells. J Biol Chem 261:3737-3743.
220. [220] Fukuda MN, Dell A, Oates JE, Wu P, Klock PC, Fukuda M. Structure of glycosphingolipids isolated from human granulocytes. J Biol Chem 260:1067-1082, 1985.
221. [221] Kawashima H, Yamamoto K, Osawa T, Irimura T. Purification and characterization of UDP-GlcNAc:Galbl-4Glc(NAc)β-1,3-N-acetylglucosaminyltransferase (poly-N-acetyllactosamine extension enzyme) from calf serum. J Biol Chem 268:27118-27126, 1993.
222. a antigen. J Biol Chem 260:9388-9392, 1985.
223. [223] Wen DX, Livingston BD, Medzihradszky KF, Kelm S, Burlingame AL, Paulson JC. Primary structure of Galβ1,3(4)GlcNAc χ2,3-sialyltransferase determined by mass spectrometry sequence analysis and molecular cloning. J Biol Chem 267:21011-21019, 1992.
224. [224] Kitagawa H, Paulson JC. Cloning and expression of human Galβ 1,3(4)GlcNAc χ2,3-sialyltransferase. Biochem Biophys Res Comm 194:375-382, 1993.
225. [225] Gillespie W, Kelm S, Paulson JC. Cloning and expression of the Galβ1,3GlcNAc χ22.3-sialyltransferase. J Biol Chem 267:21004-21010, 1992.
226. [226] Wlasichuk KB, Kashem MA, Nikrad PV, Bird P, Jiang C, Venot AP. Determination of the specificities of rat liver Gal(β 1-4)GlcNAc χ2.6-sialyltransferase and Gal(β1-3/ 4)GleNAc χ2.3-sialyltransferase using synthetic modified acceptors. J Biol Chem 268:13971-13977, 1993.
227. [227] Sasaki K, Watanabe E, Kawashima K, Sekine S, Dohi T, Oshima M, Hanai N, Nishi T, Hasegawa M. Expression cloning of a novel Galβ(1-3/1-4)GlcNAc χ2,3-sialyltransferase using lectin resistance selection. J Biol Chem 268:22782-22787, 1993.
228. - phenotype in developing thymocytes. J Biol Chem 268:3801-3804, 1993.
229. [229] Kukowska-Latallo JF, Larsen RD, Nair RP, Lowe JB. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group χ(1,3/ 1,4)fucosyltransferase. Gene Dev 4:1288-1203, 1990.
230. [230] Elmgren A, Rydberg L, Larson G. Genotypic heterogeneity among Lewis negative individuals. Biochem Biophys Res Comm 196:515-520, 1993.
231. [231] Nishihara S, Yazawa S, Iwasaki H, Nakazato M, Kudo T, Ando T, Narimatsu H. χ(1,3 1,4)fucosyltransferase (FucT-III) gene is inactivated by a single amino acid substitution in Lewis histo-blood type negative individuals. Biochem Biophys Res Comm 196:624-631, 1993.
232. [232] Potvin B, Kumar R, Howard D, Stanley P. Transfection of a human χ-(1,3)fucosyltransferase gene into Chinese hamster ovary cells. J Biol Chem 265:1615-1622, 1990.
233. [233] Goetz SE, Hession C, Goff D, Griffiths B, Tizard R, Newman B, Ghi-Rosso G, Lobb R. ELFT: A gene that directs the expression of an ELAM-1 ligand. Cell 63:1349-1356, 1990.
234. [234] Lowe JB, Kukowska-Latallo JF, Nair RP, Larsen RD, Marks RM, Macher BA, Kelly RJ, Ernst LK. Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1 dependent cell adhesion. J Biol Chem 266:17467-17477, 1991.
235. [235] Weston BW, Nair RP, Larsen RD, Lowe JB. Isolation of a novel human χ(1,3)fucosyltransferase gene and molecular comparison to the human Lewis blood group χ(1,3/ 1,4)fucosyltransferase gene. Syntenic, homologous, nonallelic genes encoding enzymes with distinct acceptor substrate specificities. J Biol Chem 267, 4152-4260, 1992.
236. [236] Weston BW, Smith PL, Kelly RJ, Lowe JB. Molecular cloning of a fourth member of a human χ(1,3)fucosyltransferase gene family. Multiple homologous sequence that determine expression of the Lewis x, sialyl Lewis x, and difucosyl sialyl Lewis x epitopes. J Biol Chem 267:24575-24584, 1992.
237. [237] Kumar R, Potvin B, Muller WA, Stanley P. Cloning of a human χ(1,3)-fucosyltransferase gene that encodes ELFT but does not confer ELAM-1 recognition on Chinese hamster ovary cell transfectants. J Biol Chem 266:21777-21783, 1991.
238. [238] Koszdin KL, Bowen BR. The cloning and expression of a human χ-1,3-fucosyltransferase capable of forming the E-selectin ligand. Biochem Biophys Res Comm 187:152-157, 1992.
239. [239] Couillin P, Mollicone R, Grisard MC, Gibuad A, Ravise N, Feingold J, Oriol R. Chromosome 11q localization of one of the three expected gene for the human χ-3-fucosyltransferase, by somatic hybridization. Cytogenet Cell Genet 56:108-111, 1991.
240. [240] Nishihara S, Nakazato M, Kudo T, Kimura H, Ando T, Narimatsu H. Human χ-1.3 fucosyltransferase (FucT-VI) gene is located at only 13Kb3′ to the Lewis type fucosyltransferase (FucT-III) gene on chromosome 19. Biochem Biophys Res Comm 190:42-46, 1992.
241. [241] Ohmori K, Takada A, Ohkawa I, Takahashi N, Furukawa Y, Maeda M, Kiso M, Hasegawa A, Kannagi M, Kannagi R. A distinct type of sialyl Lewis X antigen defined by a novel monoclonal antibody is selectively expressed on helper memory T cells. Blood 82:2797-2805, 1993.
242. a, the carbohydrate ligands for E- and p-selectins, in human malignant cell lines. Cancer Res 53:5559-5565, 1993.
243. [243] Natsuka S, Gersten KM, Zenita K, Kannagi R, Lowe JB. Molecular cloning of a cDNA encoding a novel human leukocyte χ-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant. J Biol Chem 269:16789-16794, 1994.
244. [244] Mollicone B, Reguigne I, Fletcher A, Aziz A, Rustam M, Weston BW, Kelly RJ, Lowe JB, Oriol R. Molecular basis for plasma χ(1,3)-fucosyltransferase gene deficiency (FUT6). J Biol Chem 269:12662-12671, 1994.
245. [245] Lowe JB, Stoolman LM, Nair RP, Larsen RD, Berhend TL, Marks RM. ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA. Cell 63:475-484, 1990.
246. x. Nature 250:1130-1132, 1990.
247. [247] Walz G, Aruffo A, Kolanus W, Bevilacqua M, Seed B. Recognition by ELAM-1 of the sialyl-LeX determinant on myeloid and tumor cells. Nature 250:1132-1135, 1990.
248. [248] Stoolman LM. Adhesion molecules controlling lymphocyte migration. Cell 56:907-910, 1989.
249. [249] Springer TA. Adhesion receptors for immune system. Nature 346:425-434, 1990.
250. [250] Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258:964-969, 1992.
251. [251] Bevilacqua MP, Nelson RN. Selectins. J Clin Invest 91:379-387, 1993.
252. [252] Green PJ, Tamatani T, Watanabe M, Miyasaka M, Hasegawa A, Kiso M, Yuen C-T, Feizi T. High affinity binding of the leukocyte adhesion molecule L-selectin to 3′-sulphated-Lea and -LeX oligosaccharides and the predominance of sulphate in this interaction demonstrated by binding studies with a series of lipid-linked oligosaccharide. Biochem Biophys Res Comm 188:244-251, 1992.
253. [253] Yuen C-T, Lawson AM, Chai W, Larkin M, Stoll MS, Stuart AC, Sullivan FX, Ahern TJ, Feizi T. Novel sulfated ligands for the cell adhesion molecule E-selectin revealed by the neoglycolipid technology among O-linked oligosaccharides on an ovarian cystadenoma glycoprotein. Biochemistry 31:9126-9131, 192.
254. [254] Suzuki Y, Toda Y, Tamatani T, Watanabe T, Suzuki T, Nakao T, Murase K, Kiso M, Hasegawa A, Todano-Ariyomi K, Ishizuka I, Miyasaka M. Sulfated glycolipids are ligands for a lymphocyte homing receptor. L-selectin (LECAM-1), binding epitope in sulfated sugar chain. Biochem Biophys Res Comm 190:426-434, 1993.
255. X tetrasaccharide: A potential ligand for selectin-type adhesion molecules. Biochem Biophys Res Comm 194:358-367, 1993.
256. a A superior oligosaccharide ligand for human selectin. J Biol Chem 269:1595-1598, 1994.
257. [257] Brandley BK, Kiso M, Abbas S, Nikrad P, Srivasatava O, Foxall C, Oda Y, Hasegawa A. Structure-function studies on selectin carbohydrate ligands. Modifications to fucose, sialic acid and sulphate as a acid sialic acid replacement. Glycobiology 3:633-639, 1993.
258. [258] Handa K, Nudelman ED, Stroud MR, Shiozawa T, Hakomori S. Selectin GMP-140 (CD62; PADGEM) binds to sialyl-Lea and sialosyl-LeX, sulfated glycans modulate this binding. Biochem Biophys Res Comm 181:1223-1230, 1991.
259. [259] Berg EL, Robinson MK, Mansson O, Butcher EC, Magnani JL. A carbohydrate domain common to both sialyl Lea and sialyl LeX is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J Biol Chem 266:14869-14872, 1991.
260. [260] Nelson RM, Dolich S, Aruffo A, Cecconi O, Bevilacqua M. Higher-affinity oligosaccharide ligands for E-selectin. J Clin Invest 91:1157-1166, 1993.
261. [261] Matsusako T, Muramatsu H, Shirahama T, Muramatsu T, Ohi Y. Expression of a carbohydrate signal, sialyl dimeric LeX antigen, is associated with metastatic potential of transitional cell carcinoma of the human urinary bladder. Biochem Biophys Res Comm 181:1218-1222, 1991.
262. [262] Matsumoto H, Muramatsu H, Muramatsu T, Shimazu H. Carbohydrate profiles shown by a lectin and a monoclonal antibody correlates with metastatic potential and prognosis of human lung carcinomas. Cancer 69:2084-2090, 1992.
263. [263] Inufusa H, Kojima N, Yasutomi M, Hakomori S. Human lung adenocarcinoma cell lines with different lung colonization potential (LCP), and a correlation between expression of sialosyl dimeric LeX (defined by MAb FH6) and LCP. Clin Exp Metastasis 9:245-257, 1991.
264. [264] Saitoh O, Wang W-L, Lotan R, Fukuda M. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 267:5700-5711, 1992.
265. [265] Sawada R, Lowe JB, Fukuda M. E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lysosomal membrane glycoprotein-1 expression levels. J Biol Chem 268:12675-12681, 1993.
266. [266] Kawai T, Suzuki M, Kase K, Ozeki Y. Expression of carbohydrate antigens in human pulmonary adenocarcinoma. Cancer 72:1581-1587, 1993.
267. [267] Majuri M-L, Mattila P, Renkonen R. Recombinant E-selectin-protein mediates tumor cell adhesion via sialyl-Le a and sialyl Le x. Biochem Biophys Res Comm 182:1376-1382, 1992.
268. [268] Takada A, Ohmori R, Takasaki K, Tsuyuoka K, Yago K, Zenita K, Hasegawa A, Kannagi R. Adhesion of human cancer cells to vascular endothelium mediated by carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Comm 179:713-719, 1991.
269. [269] Takada A, Ohmori K, Yoneda T, Tsutuoka K, Hasegawa A, Kiso M, Kannagi R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 53:354-361, 1993.
270. [270] Kundendorf U, Krueger-Krasagakes S, Notter M, Hock H, Walz G, Diamantstein T. A sialyl-Lex-negative melanoma cell line binds to E-selectin but not to P-selectin. Cancer Res 54:109-1112, 1994.
271. [271] Steinhoff G, Behrend M, Schrader B, Duijvestijn AM, Wonigeit K. Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia. Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3. Am L Pathol 142:481-488, 1993.
272. [272] Maehara M, Yagita M, Isobe Y, Hoshino T, Nakagawara G. Dimethyl sulfoxide (DMSO) increases expression of sialyl Lewis X antigen and enhances adhesion of human gastric carcinoma (NUGC4) cells to activated endothelial cells. Int J Cancer 54:296-301, 1993.
273. [273] Liepkalns VA and Icard-Liepkalns C. Retinoic-cid-induced augmentation on molecular species carrying sialosyl Lewis a antigen in colorectal carcinoma cell culture. Int J Cancer 55:256-261, 1993.
274. [274] Stocks S and Kerr MA. Neutrophil NCA-160(CD66) is the major protein carrier of selectin binding carbohydrate groups LewisX and sialyl LewisX. Biochem Biophys Res Comm 195:478-483, 1993.
275. [275] Kuijpers TW, van der Schoot, Hoogerwerf M, Roos D. Cross-linking of the carcinoembryonic antigen-like glycoproteins CD66 and CD67 induces neutrophilic aggregation. J Immunol 151:4934-4940, 1993.
276. [276] Fukuda M, Spooncer E, Oates JE, Dell A, Klock JC. Structure of sialylated fucosyl lactosaminoglycan isolated from hyman granulocyte. J Biol Chem 259:10925-10935, 1984.
277. [277] Sawada R, Jardime KA, Fukuda M. The genes for major lysosomal membrane glycoproteins. Lamp-1 and Lamp-2, 5′-flanking sequence of Lamp-2 gene and comparison of exon organization in two genes. J Biol Chem 268:9014-9022, 1993.
278. [278] Sawada R, Tsuboi S, Fukuda M. Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 269:1425-1431, 1994.
279. [279] Swallow DM, Gendler S, Griffiths B, Corney G, Taylor-Papadimitriou J, Bramwell ME. The human tumour-associated epithelial mucins are coded by an expressed hypervariable gene locus PUM. Nature 328:82-84, 1987.
280. [280] Gum JR. Mucin genes and the proteins they encode: Structure, diversity, and regulation. Am J Respir Cell Mol Biol 7:557-564, 1992.
281. [281] Bobek LA, Tsai H, Biesbrock AR, Levine MJ. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem 268:20563-20569, 1993.
282. [282] Siddiqui L, Abe M, Hayes D, Shani E, Yunis E, Kufe D. Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci USA 85:2320-2323, 1985.
283. [283] Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, Duhig T, Peat N, Burchell J, Pemberton L, Lanani El-N, Wilson D. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 265:15286-15293, 1990.
284. [284] Lan MS, Batra SK, Qi W-N, Metzger RS, Hollingworth MA. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem 265:15294-15299, 1990.
285. [285] Stern L, Palatsides M, de Kretser T, Ford M. Expression of the tumor-associated mucin MUC1 in an ovarian tumor cell line. Int J Cancer 50:783-790, 1992.
286. [286] Bara J, Perez IS, Imai K, Yachi A, Oriol R. A fucose residue can mask the MUC-1 epitopes in normal and cancerous gastric mucosae. Int J Cancer 54:607-613, 1993.
287. [287] Dahiya R, Kwak K-S, Byrd JC, Ho S, Yoon W-H, Kim YS. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene. Cancer Res 53:1437-1443, 1993.
288. [288] Peat N, Gendler SJ, Lalani E-N, Taylor-Papadimitriou J. Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice. Cancer Res 52:1954-1960, 1992.
289. [289] Gum JR, Byrd JC, Hicks W, Toribara NW, Lamport DTA, Kim YS. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem 264:6480-6487, 1989.
290. [290] Gerard C, Eddy RL, Shows TB. The core polypeptide of cystic fibrosis tracheal mucin contains a tandem repeat structure. Evidence for a common mucin in airway and gastrointestinal tissue. J Clin Invest 86:1921-1927, 1990.
291. [291] Chang S-K, Dohrman AF, Basbaum CB, Ho SB, Tsuda T, Toribara NW, Gum JR, Kim YS. Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer. Gastroenterology 107:28-36, 1994.
292. [292] Gum JR, Hicks JW, Toribara NW, Siddiki B, Kim YS. Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor. J Biol Chem 269:2440-2446, 1994.
293. [293] Gendler S, Taylor-Papadimitriou J, Duhig T, Rothbard J, Burchell J. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 263:12820-12823, 1988.
294. [294] Kotera Y, Fontenot D, Pecher G, Metzger RS, Finn OJ. Humoral immunity against a tandem repeat epitope of human mucin MLC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res 54:2856-2860, 1994.
295. [295] Ogata S, Uehara H, Chen A, Itzkowitz SH. Mucin gene expression in colonic tissues and cell lines. Cancer Res 52:5971-5978, 1992.
296. [296] Braga VMM, Gendler SJ. Modulation of Muc-1 mucin expression in the mouse uterus during the estrus cycle, early pregnancy and placentation. J Cell Sci 105:397-405, 1993.
297. [297] Chambers JA, Hollingsworth MA, Trezise AEO, Harris A. Developmental expression of mucin genes MUC1 and MUC2. J Cell Sci 107:413-424, 1994.
298. [298] Dohi DF, Sutton RS, Fraizer ML, Nakamori S, McIssac AM, Irimura T. Regulation of sialomucin production in colon carcinoma cells. J Biol Chem 268:10133-10138, 1993.
299. [299] Shirotani K, Taylor-Papadimitriou J, Gendler SJ, Irimura T. Transcriptional regulation of the MUC1 mucin gene in colon carcinoma cells by a soluble factor. Identification of a regulatory element. J Biol Chem 269:15030-15035, 1994.
300. [300] Mack DR, Hollingsworth MA. Alteration in expression of MUC2 and MUC3 mRNA levels in HT29 colonic carcinoma cells. Biochem Biophys Res Comm 199:1012-1018, 1994.
301. [301] Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 106:353-361, 1994.
302. [302] Yamashita K, Yonezawa S, Tanaka S, Shirahama H, Sakoda K, Imai K, Xing P-X, McKenzie IFC, Hilkens J, Kim YS, Sato E. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int J Cancer 55:82-91, 1993.
303. [303] Osako M, Yonezawa S, Siddiki B, Huang J, Ho JJ, Kim YS, Sato E. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. Cancer 71:2191-2199, 1993.